Research into microRNAs (miRNAs) - small non-coding RNA molecules that regulate gene expression - has unveiled their potential as both biomarkers and therapeutic targets in breast cancer. By modulating the activity of genes involved in cancer growth and metastasis, miRNA-based therapies could offer a novel approach to treatment, either by inhibiting oncogenic miRNAs or restoring the function of tumor-suppressor miRNAs.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.